In an AD model, inhibition of the PI3K/AKT pathway suppressed the secretion of inflammatory mediators and cytokines, reduced the proliferation of inflammatory cells in microglia and astrocytes, decreased Aβ deposition, and improved cognitive function [129]. The gene discussed is AKT1; the disease is Alzheimer disease.